New genetic analysis approach could improve diagnosis for mitochondrial disease

August 7, 2017
New genetic analysis approach could improve diagnosis for mitochondrial disease
Credit: Murdoch Childrens Research Institute

Murdoch Children's Research Institute (MCRI) scientists have shown a new approach to genetic analysis could greatly improve diagnostic rates for children with baffling and often fatal mitochondrial diseases.

Mitochondrial diseases are devastating conditions affecting babies, older children and adults. UK baby Charlie Gard suffered from a form of the condition called mitochondrial DNA depletion syndrome, which ultimately cost him his life.

Mitochondria are the power plants of cells, breaking down molecules from sugars, fats and proteins to generate energy for the human body, like burning coal to produce electricity.

Until recently, diagnosis for mitochondrial diseases has been very slow with only about a quarter of patients receiving a genetic diagnosis. Current treatments are also unsatisfactory – for example, an unproven therapy for mitochondrial DNA depletion syndrome was behind a UK court's decision for preventing Charlie Gard's family from travelling to the US to access the treatment.

However, new diagnostic methods like whole exome sequencing – which can quickly and cheaply sequence a person's entire genetic blueprint – means up to two-thirds of affected children can now be diagnosed.

However other approaches are needed to identify the difficult cases that continue to elude diagnosis.

Research led by MCRI PhD student Nicole Lake found a new cause of mitochondrial , which affects the ability of the mitochondria to operate as the body's power plant, converting food into energy.

Ms Lake said the research she led identified mutations in a gene called MRPS34, in six patients with the most common form of childhood mitochondrial disease, Leigh Syndrome, from Australia, France and the USA.

"A key approach was using quantitative proteomics. This process involves sampling all the proteins in a cell at once to identify any problems with the cellular machinery," said Ms Lake.

"Using this technique, you get a snapshot of what's happening in cells."

The MRPS34 gene is one of 80 components of the mitochondrial protein synthesis machinery, known as the 'mitoribosome'.

Co-lead author Dr David Stroud at Monash University carried out the quantitative proteomics technique, examining cellular proteins in the patient's cultured skin cells, versus healthy skin cells. This showed one half of the mitoribosome fell apart, meaning cells could not make the key proteins encoded by mitochondrial DNA.

It also showed that this led to two of the five major components of the power plants falling apart, causing the machinery that fuels the body's energy to break down.

MCRI Chief Investigator, Professor David Thorburn said MRPS34 was the 25th mitochondrial disease gene discovered by scientists at MCRI and one of the first in the world to show that quantitative proteomics could play a key role in improving diagnostic rates to closer to 100 per cent.

"This approach will therefore help to end the diagnostic odyssey for families with children suspected of mitochondrial and other inherited diseases," he said.

"Early diagnosis improves the chance for early intervention. It can also provide the opportunity to enrol patients with into clinical trials to test many new promising therapies that are in the pipeline, but not yet proven."

Sean Murray, CEO of the Australian Mitochondrial Disease Foundation (AMDF), said that this was an exciting development, which boosted one of the AMDF's major aims in improving diagnostic rates for families affected by mitochondrial disease. "I'm particularly thrilled to see an outcome like this, as it has been partly supported by the hard work of AMDF fund-raisers through activities such as our 'Bloody Long Walks' and demonstrates the value of researchers engaging with the patient community."

The research was published on Friday in the American Journal of Human Genetics.

Explore further: Mitochondrial disease has a disproportionate healthcare burden in US

More information: Nicole J. Lake et al. Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome, The American Journal of Human Genetics (2017). DOI: 10.1016/j.ajhg.2017.07.005

Related Stories

Mitochondrial disease has a disproportionate healthcare burden in US

June 28, 2017
Mitochondrial diseases are a diverse group of disorders caused by mutated genes that impair energy production in a patient's cells, often with severe effects. When patients with these diseases are hospitalized, they incur ...

Unravelling the genetic mystery behind mitochondrial disease

September 15, 2016
Researchers from the Monash Biomedicine Discovery Institute in Melbourne have identified two new genes linked to a major cause of mitochondrial disease. Their research opens the way for better genetic diagnosis of the disease ...

Pre-clinical model reveals pathology behind mitochondrial disease

April 21, 2015
A lack of a particular mitochondrial protein in genetically manipulated mice has shown to trigger events in the body that causes mild heart hypertrophy (enlargement) and severe fatty liver disease.

New rapid gene test for mitochondrial disease

July 7, 2016
Newcastle researchers have developed a genetic test providing a rapid diagnosis of mitochondrial disorders to identify the first patients with inherited mutations in a new disease gene.

Repairing fatal mutations behind mitochondrial disease

July 24, 2015
A multidisciplinary team of researchers has eliminated fatal mitochondrial DNA mutations in stem cells from patients with mitochondrial diseases. The study is published in a recent online issue of Nature as a collaboration ...

Recommended for you

Maternal diet may program child for disease risk, but better nutrition later can change that

October 20, 2017
Research has shown that a mother's diet during pregnancy, particularly one that is high-fat, may program her baby for future risk of certain diseases such as diabetes. A new study from nutrition researchers at the University ...

New gene editing approach for alpha-1 antitrypsin deficiency shows promise

October 20, 2017
A new study by scientists at UMass Medical School shows that using a technique called "nuclease-free" gene editing to correct cells with the mutation that causes a rare liver disease leads to repopulation of the diseased ...

Researchers find evidence of DNA damage in veterans with Gulf War illness

October 19, 2017
Researchers say they have found the "first direct biological evidence" of damage in veterans with Gulf War illness to DNA within cellular structures that produce energy in the body.

Researchers drill down into gene behind frontotemporal lobar degeneration

October 19, 2017
Seven years ago, Penn Medicine researchers showed that mutations in the TMEM106B gene significantly increased a person's risk of frontotemporal lobar degeneration (FTLD), the second most common cause of dementia in those ...

Genetic variants associated with obsessive-compulsive disorder identified

October 18, 2017
(Medical Xpress)—An international team of researchers has found evidence of four genes that can be linked to obsessive-compulsive disorder (OCD). In their paper published in the journal Nature Communications, the group ...

New clues to treat Alagille syndrome from zebrafish

October 18, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies potential new therapeutic avenues for patients with Alagille syndrome. The discovery, published in Nature Communications, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.